Does UMECLIDINIUM Cause Hyperphosphataemia? 90 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 90 reports of Hyperphosphataemia have been filed in association with UMECLIDINIUM (Anoro Ellipta). This represents 1.4% of all adverse event reports for UMECLIDINIUM.
90
Reports of Hyperphosphataemia with UMECLIDINIUM
1.4%
of all UMECLIDINIUM reports
90
Deaths
85
Hospitalizations
How Dangerous Is Hyperphosphataemia From UMECLIDINIUM?
Of the 90 reports, 90 (100.0%) resulted in death, 85 (94.4%) required hospitalization, and 80 (88.9%) were considered life-threatening.
Is Hyperphosphataemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UMECLIDINIUM. However, 90 reports have been filed with the FAERS database.
What Other Side Effects Does UMECLIDINIUM Cause?
Dyspnoea (1,817)
Asthma (1,433)
Wheezing (1,111)
Therapeutic product effect incomplete (980)
Cough (913)
Drug ineffective (734)
Loss of personal independence in daily activities (711)
Obstructive airways disorder (654)
Chronic obstructive pulmonary disease (588)
Condition aggravated (580)
What Other Drugs Cause Hyperphosphataemia?
ALLOPURINOL (139)
LANSOPRAZOLE (138)
ACETAMINOPHEN (132)
SEVELAMER (129)
ONDANSETRON (127)
CALCITRIOL (125)
IPRATROPIUM (123)
ALBUTEROL (122)
METRONIDAZOLE (120)
HYDROMORPHONE (118)
Which UMECLIDINIUM Alternatives Have Lower Hyperphosphataemia Risk?
UMECLIDINIUM vs UMECLIDINIUM\VILANTEROL TRIFENATATE
UMECLIDINIUM vs UMIFENOVIR
UMECLIDINIUM vs UNSPECIFIED INGREDIENT
UMECLIDINIUM vs UPADACITINIB
UMECLIDINIUM vs URAPIDIL